Moderna: Stock soars on cancer vaccine data; CEO Bancel takes on commercial role
soared to around 14% on Thursday on the news that a personalized cancer vaccine, in partnership with Merck (MRK), reduced the risk of late-stage melanoma by 49% Moderna (MRNA) has struggled to maintain Wall Street's attention on its pipeline as it recovers from the COVID vaccine highs of 2022,…#merck #stephanebancel #yahoofinance #rsv #lthe #stéphanebancel #moderna #spikevax #arpagaray #bancel (Source: Reuters: Health)
Source: Reuters: Health - December 14, 2023 Category: Consumer Health News Source Type: news

Three Years After Covid-19 Vaccine Rollout, CDC Still Gets Messaging Wrong
It ’s this kind of evidence that should be highlighted in CDC’s messaging on the importance of vaccines in the effort to prevent severe illness and death from Covid-19. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 14, 2023 Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

Final Batch Of Pfizer Documents Released By FDA
Authored by Megan Redshaw via The Epoch Times (emphasis ours), (Marco Lazzarini/Shutterstock) The FDA released the final batch of documents it relied upon in licensing Pfizer’s Comirnaty COVID-19 vaccine for ages 16 and up—more than 800 days after…#fda #meganredshaw #epochtimes #pfizer #comirnatycovid19 #foia #comirnaty #advertisementstory #sentinel #pmr (Source: Reuters: Health)
Source: Reuters: Health - December 14, 2023 Category: Consumer Health News Source Type: news

Here ’s How Many Parents Will Vaccinate Their Kids Against The ‘Tripledemic’—Covid, Flu And RSV
Only 8% of children in the U.S. have an updated Covid vaccine, and almost 42% have an updated flu vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2023 Category: Pharmaceuticals Authors: Arianna Johnson, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Breaking breaking-news Trending Explainer Trending-Explainer topline Source Type: news

Pfizer shares sink after it resets 2024 COVID expectations
Pfizer on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, a move top executives said provided a more reliable view of its COVID-19 business than it had this year, driving shares down 9% to a 10-year low. (NYSE: )'s COVID-19 vaccines and treatments…#pfizer #pfizerchiefexecutive #albertbourla #seagen #jpmorgan #chrisschott #etr #angelahwang #citi #andrewbaum (Source: Reuters: Health)
Source: Reuters: Health - December 13, 2023 Category: Consumer Health News Source Type: news